NGS Sample Preparation Market, 2024 - Opportunities in Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects

DUBLIN, May 22, 2019 /PRNewswire/ -- The "NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The NGS sample preparation market is projected to reach USD 2.7 billion by 2024 from USD 1.1 billion in 2019, at a CAGR of 18.7% during the forecast period.

The growth of this market is driven by increasing application of NGS in diagnostics and genomics research, increasing adoption of NGS for diagnostics (due to the decreasing cost of NGS products and services), and development of low-cost sequencing technologies are expected to drive the market growth in the future.

The library preparation products segment to register the highest CAGR in the NGS reagents and consumables market.

Based on workflow, the reagents & consumables segment is subsegmented into library preparation, target enrichment, and quality control. Library preparation segment is classified into DNA (Human WGS, targeted sequencing, whole exome sequencing, and others) and RNA (gene expression analysis, whole transcriptome, and others) on the basis of type.

In 2018, the library preparation segment accounted for the largest share of the NGS reagents and consumables market. Advancements in the NGS protocols for library preparation and the increasing number of research activities are driving the growth of the library preparation market.

The academic institutes & research centers segment is expected to dominate the end-user segment.

Based on end user, the NGS sample preparation market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The academic institutes & research centers segment is expected to account for the largest share the NGS sample preparation market during the forecast period.

The increasing number of collaborations between NGS market players and academic & research institutions; availability of financial support for genomics R&D across regions; and the development of cost-effective NGS products and services for researchers are the major factors supporting the growth of this end-user segment.

The NGS sample preparation market in the APAC is projected to grow at the highest rate during the forecast period.

The Asia Pacific NGS sample preparation market is expected to witness the highest CAGR from 2019 to 2024. Increasing financial support from public as well as private agencies, increasing number of NGS-based research projects, increasing awareness about precision medicine, and high incidence of chronic diseases in key APAC countries are the major factors driving the growth of this regional market.

Several companies such as Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), and Beckman Coulter (a subsidiary of Danaher), among others, are investing in high-growth markets to gain significant profits and increase their share in the NGS sample preparation market.

Market Dynamics

Drivers

• Advancements in NGS Platforms
• Declining Cost of Sequencing
• Improving Reimbursement Scenario for NGS-Based Diagnostic Tests

Restraints

• End User Budget Constraints in Developing Countries

Opportunities

• Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
• Increasing Applications of NGS

Challenges

• Ethical Issues

Company Profile

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Beckman Coulter (A Subsidiary of Danaher)
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• New England Biolabs, Inc.
• Nugen Technologies, Inc. (Part of Tecan Trading Ag)
• Oxford Gene Technology (Part of Sysmex)
• Oxford Nanopore Technologies, Ltd.
• Pacific Biosciences of California, Inc.
• Perkinelmer, Inc.
• QIAGEN N.V.
• Raindance Technologies, Inc. (Part of Bio-Rad Laboratories)
• Swift Biosciences Inc.
• Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/4hqcbh

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets